Insights

Product Updates

Introducing SARS-CoV-2 Mutation Panel 1.0 by Biomeme

EDIT: As RNA viruses like SARS-CoV-2 continue to mutate, so will this panel. Please review our COVID-19 page for the latest information regarding our testing capabilities, including variant/mutation...

Read More

Search By Topic

Get the latest tips from Biomeme shipped right to your inbox

Our People

Biomeme to Open New Headquarters at Netrality’s 401 North Broad 🍾

Biomeme has officially outgrown its home at 10th and Chestnut and is moving on to Netrality’s 401 North Broad Street for its new corporate headquarters! The new headquarters boasts 44,000 square feet...

Read More
Our Progress

The Road to Reopening K-12 Schools: Biomeme To Partner with Ginkgo Bioworks

As the world crosses the 1-year mark since the World Health Organization classified COVID-19 as a pandemic, testing is still as crucial as ever. The United States tests an average of 2.78 people per...

Read More
Our Progress

Partnership Spotlight: INDICAL Bioscience

The Partnership Back in May 2019, Biomeme and INDICAL Bioscience entered into an exclusive global licensing and research agreement in a joint effort to improve animal health globally. At the time,...

Read More
Product Explainers

What to Know About SARS-CoV-2 Variants from a Leading Manufacturer of Portable PCR Testing Solutions

Table of Contents: What is a variant? Why are we just now hearing about variants of SARS-CoV-2? What are the current emerging SARS-CoV-2 variants to know? Should we be worried about these SARS-CoV-2...

Read More
Our Progress

Biomeme Awarded RACP Grant from the Commonwealth of Pennsylvania

We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the Commonwealth of Pennsylvania. This RACP Grant will enable our...

Read More
Product Updates

Biomeme’s SARS-CoV-2 Assay Detects All Current Variants of Concern and Interest

List of SARS-CoV-2 Variants & Classifications Biomeme continuously monitors and analyzes sequences of emerging variants of concern and updates this table accordingly. Variant CDC Label CDC Variant...

Read More
Our Progress

Biomeme Selected as XPRIZE Rapid Covid Testing Finalist

The finalists have been announced and Biomeme is moving forward to the next round of XPRIZE Rapid COVID Testing, a $6 million dollar 6-month competition to create increased and more accessible...

Read More
Our Progress

Biomeme Goes Back to Its Roots in New Mexico

When you walk into Biomeme HQ in Philadelphia, you’ll find a bustling office overflowing with our staff, incoming and outgoing packages, and an overworked coffee machine (our office appliances might...

Read More
Our Progress

Biomeme Selected as XPRIZE Rapid Covid Testing Semi-Finalist

Launched on July 28, 2020, XPRIZE Rapid Covid Testing is a $5 million, 6-month competition that aims to increase Covid-19 testing capabilities 100-times past our current standard, the level of...

Read More
Prev 2 3 4 5 6 Next